Reduced ubiquitin-specific protease 9X expression induced by RNA interference inhibits the bioactivity 
of hepatocellular carcinoma cells

Hu,Huiwen; Tang,Chengyong; Jiang,Qinghu; Luo,Wei; Liu,Jiming; Wei,Xufu; Liu,Rui; Wu,Zhongjun

doi:10.3892/ol.2015.3152

July-2015 Volume 10 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

July-2015 Volume 10 Issue 1

Full Size Image

Article

Reduced ubiquitin-specific protease 9X expression induced by RNA interference inhibits the bioactivity of hepatocellular carcinoma cells

Authors:
- Huiwen Hu
- Chengyong Tang
- Qinghu Jiang
- Wei Luo
- Jiming Liu
- Xufu Wei
- Rui Liu
- Zhongjun Wu
View Affiliations / Copyright

Affiliations: Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China, Department of Clinical Pharmacology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China
Pages: 268-272
|
Published online on: April 27, 2015

https://doi.org/10.3892/ol.2015.3152
Expand metrics +

Abstract

Ubiquitin-specific protease 9X (USP9X) is crucial in many tumor types, but not in hepatocellular carcinoma (HCC). The current study aimed to examine the effects of RNA interference on USP9X expression, and subsequently on the bioactivity of HCC SMMC7721 and HepG2 cells. The protein expression of USP9X in SMMC7721, HepG2 and normal human liver cell line L02 at the cellular level was determined by western blot analysis; USP9X was knocked down by small interfering RNA (siRNA) in HCC SMMC7721 and HepG2 cells. In vitro cell viability was assessed by MTT assay, apoptosis was determined by flow cytometry (FCM) and cell migration was evaluated by Transwell assays. The protein expression of USP9X in SMMC7721 and HepG2 were both significantly higher than that in L02 (P<0.01). The results of western blot demonstrated that the USP9X‑siRNA could efficiently inhibit USP9X expression when compared with that of the negative control (NC) group (P<0.01) and MTT assay demonstrated that cell proliferation in USP9X‑blocked cells was significantly reduced when compared with that of the NC group (P<0.01). The results of FCM revealed that apoptosis was significantly increased in USP9X‑blocked cells when compared with that of the NC group (P<0.01). The results of transwell assay showed that cell migration was significantly inhibited in USP9X‑blocked cells when compared with that of the NC group (P<0.01). These results show that expression of USP9X is upregulated in hepatoma cells SMMC7721 and HepG2, and that downregulating USP9X by siRNA may induce cell apoptosis, inhibit cell growth and cell migration in the HCC SMMC7721 and HepG2 cell lines. USP9X may therefore be a potential target for HCC treatment and early detection.

View Figures

View References

1	Llovet JM, Burroughs A and Bruix J: Hepatocellular carcinoma. Lancet. 362:1907–1917. 2003. View Article : Google Scholar : PubMed/NCBI
2	Marrero JA: Multidisciplinary management of hepatocellular carcinoma: where are we today? Semin Liver Dis. 33(Suppl 1): 3–10. 2013.PubMed/NCBI
3	Yau T, Chan P, Epstein R and Poon RT: Evolution of systemic therapy of advanced hepatocellular carcinoma. World J Gastroenterol. 14:6437–6441. 2008. View Article : Google Scholar : PubMed/NCBI
4	El-Serag HB and Rudolph KL: Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
5	Peddaboina C, Jupiter D, Fletcher S, et al: The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition. BMC Cancer. 12:5412012. View Article : Google Scholar : PubMed/NCBI
6	DiAntonio A and Hicke L: Ubiquitin-dependent regulation of the synapse. Annu Rev Neurosci. 27:223–246. 2004. View Article : Google Scholar : PubMed/NCBI
7	Yang Bo and XIEcong Hua: Ubiquitin specific peptidase 9X and tumor. J Int Oncol. 38:900–902. 2011.
8	Kitagawa K, Kotake Y and Kitagawa M: Ubiquitin-mediated control of oncogene and tumor suppressor gene products. Cancer Sci. 100:1374–1381. 2009. View Article : Google Scholar : PubMed/NCBI
9	Becuwe M, Herrador A, Haguenauer-Tsapis R, Vincent O and Léon S: Ubiquitin-mediated regulation of endocytosis by proteins of the arrestin family. Biochem Res Int. 2012:122012.
10	Deng S, Zhou H, Xiong R, et al: Over-expression of genes and proteins of ubiquitin specific peptidases (USPs) and proteasome subunits (PSs) in breast cancer tissue observed by the methods of RFDD-PCR and proteomics. Breast Cancer Res Treat. 104:21–30. 2007. View Article : Google Scholar : PubMed/NCBI
11	Sun H, Kapuria V, Peterson LF, et al: Bcr-Abl ubiquitination and Usp9X inhibition block kinase signaling and promote CML cell apoptosis. Blood. 117:3151–3162. 2011. View Article : Google Scholar : PubMed/NCBI
12	Kapuria V, Peterson LF, Fang D, Bornmann WG, Talpaz M and Donato NJ: Deubiquitinase inhibition by small-molecule WP1130 triggers aggresome formation and tumor cell apoptosis. Cance Res. 70:9265–9276. 2010. View Article : Google Scholar
13	Schwickart M, Huang X, Lill JR, et al: Deubiquitinase USP9X stabilizes MCL1 and promotes tumor cell survival. Nature. 463:103–107. 2010. View Article : Google Scholar : PubMed/NCBI
14	Xie Y, Avello M, Schirle M, et al: Deubiquitinase FAM/USP9X interacts with the E3 ubiquitin ligase SMURF1 protein and protects it from ligase activity-dependent self-degradation. J Biol Chem. 288:2976–2985. 2013. View Article : Google Scholar : PubMed/NCBI
15	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
16	Schulze-Bergkamen H, Fleischer B, Schuchmann M, et al: Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction. BMC Cancer. 6:2322006. View Article : Google Scholar : PubMed/NCBI
17	Sieghart W, Losert D, Strommer S, et al: Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy. J Hepatol. 44:151–157. 2006. View Article : Google Scholar : PubMed/NCBI